Home
/
Records
/
145
/
Portland Compounding Pharmacy

145

•Portland Compounding Pharmacy•April 7, 2020

FDA 145 - Portland Compounding Pharmacy - April 07, 2020

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Record Details

This 145 record concerns Portland Compounding Pharmacy, with an inspection on April 7, 2020, covering drugs.

Company: Portland Compounding Pharmacy
Inspection Date: April 7, 2020
Product Type: Drugs
Person: Steven E. Porter (Program Division Director)

Open in Dashboard

ID · 8a3d9046-1fc8-4045-b7ab-1322e610a46d

Violation Codes2

21 CFR 2021 CFR 20.64(d)(3)

Full citation text and observation details available on the Dashboard.

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

[email protected]

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA 145 - Portland Compounding Pharmacy - April 07, 2020 | Global Key Solutions